Related Experiment Video
Updated: Jul 16, 2026
06:16
White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
Leptin and hypertension in obesity
Paco E Bravo1, Stephen Morse, David M Borne
1Section of Nephrology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Vascular Health and Risk Management
|February 27, 2007
Summary
Leptin resistance in obesity preserves sympathetic activation, potentially causing hypertension. This hormone
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Metabolic Research
Background:
- Leptin, a peptide hormone, regulates appetite and energy expenditure.
- Initially considered an anti-obesity agent due to its metabolic effects.
- Obesity is associated with leptin resistance, impairing its weight-reducing effects.
Purpose of the Study:
- To investigate the role of leptin in the development of hypertension in obesity.
- To explore the mechanisms linking leptin to elevated blood pressure.
Main Methods:
- Review of existing literature on leptin, obesity, and hypertension.
- Analysis of leptin's effects on sympathetic nerve activity and cardiovascular parameters.
- Examination of leptin's influence on nitric oxide production and natriuresis.
Main Results:
- Obese individuals exhibit leptin resistance to satiety but maintain sympathetic activation.
- Leptin-mediated sympathetic activation targets non-thermogenic tissues like the kidney.
- Chronic sympathetic activation, particularly renal, may promote sodium retention and vasoconstriction.
Conclusions:
- Leptin plays a significant role in obesity-induced hypertension.
- Leptin resistance paradoxically contributes to cardiovascular complications in obesity.
- Further research is warranted to elucidate leptin's precise role in hypertensive mechanisms.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...